Added to YB: 2025-10-28
Pitch date: 2025-10-24
MBOT [bullish]
Microbot Medical Inc.
-26.45%
current return
Author Info
Ridire Research is an independent equity research platform focused on actionable, high-conviction long/short equity ideas. We combine fundamental rigor with quantitative structure to identify mispriced opportunities others overlook. Sign up for the newsletter.
Company Info
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.
Market Cap
$145.7M
Pitch Price
$2.42
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.71
P/E
-8.37
EV/Sales
706.01
Sector
Health Care Equipment and Supplies
Category
growth
Microbot Medical (MBOT) — Disposable Robotics, Infinite Leverage
MBOT: Pioneering fully disposable endovascular micro-robotic system LIBERTY w/ FDA Breakthrough designation. Category-creating IP moat, enables remote procedures at small hospitals. Binary bet on 2025-26 FDA approval & pivotal trial data. Risks: manufacturing scale-up, reimbursement coding, dilution. Convex upside if first-mover captures multibillion TAM.
Read full article (2 min)